C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results

We previously reported that higher serum concentrations of C-reactive protein (CRP) are associated with shorter survival in men with castration-resistant prostate cancer (CRPC). To confirm this finding in an independent data set, we used 119 CRPC patients enrolled in 6 phase II clinical trials and e...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Prins, Renee C., Rademacher, Brooks L., Mongoue-Tchokote, Solange, Alumkal, Joshi J., Graff, Julie N., Eilers, Kristine M., Beer, Tomasz M.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2894303/
https://ncbi.nlm.nih.gov/pubmed/20207556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2009.11.012
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares